Laboratory of Molecular Genetics, Instituto de Tecnologia Química e Biológica António Xavier (ITQB), Universidade Nova de Lisboa (UNL), Oeiras, Portugal.
Laboratory of Molecular Genetics, Instituto de Tecnologia Química e Biológica António Xavier (ITQB), Universidade Nova de Lisboa (UNL), Oeiras, Portugal; Laboratory of Microbiology and Infectious Diseases, The Rockefeller University, New York, NY, USA.
J Glob Antimicrob Resist. 2021 Mar;24:169-174. doi: 10.1016/j.jgar.2020.12.010. Epub 2020 Dec 26.
Methicillin-resistantStaphylococcus aureus (MRSA) remains a major human pathogen. MRSA decolonisation strategies frequently combine chlorhexidine baths and mupirocin nasal ointment. Although MRSA remains widespread in Portuguese hospitals, information regarding resistance to biocides and mupirocin is scarce. We evaluated the prevalence of biocide resistance genes and chlorhexidine and mupirocin non-susceptibility in a representative and well-characterised collection of MRSA isolated in Portuguese hospitals during a 31-year period (1985-2016).
Prevalence of five biocide resistance genes (lmrS, mepA, sepA, qacAB and smr) was determined by PCR. Antibiotic susceptibility was assessed by disk diffusion and by MIC determination using broth microdilution (chlorhexidine) and Etest (mupirocin).
Chromosomal genessepA and mepA were detected in all isolates, while lmrS was found in 87.1%. The prevalence of plasmid-borne genes was significant for qacAB (22.4%), associated with the Iberian (ST247-I/IA) clone (P < 0.0001), and low for smr (1.0%) detected among isolates belonging to the ST239-III/IIIvariant clone. Chlorhexidine non-susceptibility (MIC ≥ 4 mg/L) was observed in two isolates belonging to the EMRSA-15 clone (ST22-IV). Non-susceptibility to mupirocin (MIC > 1 mg/L) was significant (15.4%; n = 31) and mainly found among isolates of the EMRSA-15 clone (P < 0.0001; n = 29). One isolate presented low-level mupirocin resistance (MIC = 32 mg/L), and two missense mutations N213D (A637G) and V588F (G1762T) were identified in the ileS gene.
Concerningly, we detected a high prevalence of biocide resistance genes and an association of mupirocin and chlorhexidine non-susceptibility with the dominant EMRSA-15 clone in Portuguese hospitals.
耐甲氧西林金黄色葡萄球菌(MRSA)仍然是一种主要的人类病原体。MRSA 去定植策略通常结合洗必泰和莫匹罗星鼻软膏。尽管 MRSA 在葡萄牙医院仍然广泛存在,但关于消毒剂和莫匹罗星抗性的信息却很少。我们评估了在 31 年期间(1985-2016 年)从葡萄牙医院分离的具有代表性和特征良好的 MRSA 代表菌株中,消毒剂耐药基因和氯己定及莫匹罗星非敏感性的流行率。
通过 PCR 确定了 5 种消毒剂耐药基因(lmrS、mepA、sepA、qacAB 和 smr)的流行率。通过纸片扩散法和肉汤微量稀释法(氯己定)和 Etest(莫匹罗星)测定 MIC 来评估抗生素敏感性。
所有分离株均检测到染色体基因 sepA 和 mepA,而 lmrS 的检出率为 87.1%。qacAB 携带的质粒基因的流行率显著(22.4%),与伊比利亚(ST247-I/IA)克隆相关(P<0.0001),而 smr 的检出率较低(1.0%),仅见于 ST239-III/III 变体克隆的分离株。属于 EMRSA-15 克隆的 2 个分离株对氯己定(MIC≥4mg/L)表现出不敏感性。对莫匹罗星(MIC>1mg/L)的不敏感性显著(15.4%;n=31),主要见于 EMRSA-15 克隆的分离株(P<0.0001;n=29)。一个分离株表现出低水平的莫匹罗星耐药性(MIC=32mg/L),并且在 ileS 基因中鉴定到 2 个错义突变 N213D(A637G)和 V588F(G1762T)。
令人担忧的是,我们在葡萄牙医院检测到高消毒剂耐药基因流行率,并且与主要的 EMRSA-15 克隆相关的莫匹罗星和氯己定非敏感性。